West Midlands Ambulance Service's board heard on 28 October 2026 that handover delays had deteriorated, with crews losing 32,810 hours outside hospitals in September, up from 20,194 hours in April, and its patient safety director said patient harm was happening.
Health6 November 20264 min readSources 13
Takeda Biopharmaceuticals has signed an exclusive agreement for Dr Reddy's Laboratories to promote and distribute Takeda's Qdenga dengue vaccine in India's private market, with the shot expected in the first half of 2027.
Health6 November 20263 min readSources 6
South Korea's health ministry said on 27 October 2026 that it would review obesity drugs such as Wegovy for its managed benefit scheme. Combined Wegovy and Mounjaro prescriptions from January to August reached 2.3 times last year's full total.
Health6 November 20265 min readSources 18
An analysis presented on 28 October at the Academy of Managed Care Pharmacy's Nexus 2026 estimated an all-payer sickle cell gene therapy pool would cost insurers 11 cents per member per month, with a range of 2 to 22 cents.
Health6 November 20266 min readSources 34
Italy reported 653 measles cases in the 12 months to 31 August 2026, the most in the EU/EEA and 28% of the 2,335 total, with second-dose vaccination coverage at 84.45%, below the WHO's 95% threshold.
Health6 November 20263 min readSources 30
Amgen has begun a Phase 3 trial of at-home self-administration of subcutaneous MariTide using an autoinjector, a device that could let the obesity drug match the pens sold by Novo Nordisk and Eli Lilly. The study's primary completion date is June 2027.
Health6 November 20264 min readSources 33